7-15366201-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001004320.2(AGMO):c.1096C>T(p.Leu366Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000156 in 1,607,364 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004320.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AGMO | NM_001004320.2 | c.1096C>T | p.Leu366Phe | missense_variant | 11/13 | ENST00000342526.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AGMO | ENST00000342526.8 | c.1096C>T | p.Leu366Phe | missense_variant | 11/13 | 1 | NM_001004320.2 | P1 | |
AGMO | ENST00000418075.1 | c.22C>T | p.Leu8Phe | missense_variant | 1/3 | 3 | |||
AGMO | ENST00000407277.6 | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152064Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000412 AC: 1AN: 242756Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 131260
GnomAD4 exome AF: 0.0000165 AC: 24AN: 1455300Hom.: 0 Cov.: 30 AF XY: 0.0000152 AC XY: 11AN XY: 723674
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152064Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2022 | The c.1096C>T (p.L366F) alteration is located in exon 11 (coding exon 11) of the AGMO gene. This alteration results from a C to T substitution at nucleotide position 1096, causing the leucine (L) at amino acid position 366 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at